secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2022-08-01T23:59:59+00:00
Accession:  0001558370-22-011455
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q2 revenue $59.6M (+17% YoY); raises FY22 revenue guidance to $238-242M
--------------------------------------------------------------------------------

- Net loss $4.6M ($0.23/share) vs net income $1.3M ($0.07) in Q2 2021; adjusted EBITDA $1.7M vs $4.1M.
- Airway clearance products added $8.0M revenue; lymphedema sales up 1% YoY.
- Full-year 2022 revenue guidance raised to $238-242M from prior $235-240M (14-16% growth).
- Operating loss widened to $4.1M from $0.1M; cash $23.4M, debt $50.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837022011455/0001558370-22-011455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837022011455/tcmd-20220801x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-011455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer